P807-0393 Screening compound: 2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-{[1-(3-phenyl-1H-pyrazol-5-yl)piperidin-4-yl]methyl}acetamide

P807-0393 Screening compound: 2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-{[1-(3-phenyl-1H-pyrazol-5-yl)piperidin-4-yl]methyl}acetamide
P807-0393 Screening compound: 2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-{[1-(3-phenyl-1H-pyrazol-5-yl)piperidin-4-yl]methyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P807-0393
2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-{[1-(3-phenyl-1H-pyrazol-5-yl)piperidin-4-yl]methyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P807-0393

Molecular Formula

C22H27N5O2 (C22 H27 N5 O2)

Compound Name

2-(3,5-dimethyl-1,2-oxazol-4-yl)-N-{[1-(3-phenyl-1H-pyrazol-5-yl)piperidin-4-yl]methyl}acetamide

IUPAC name

2-(35-dimethyl-12-oxazol-4-yl)-N-{[1-(3-phenyl-1H-pyrazol-5-yl)piperidin-4-yl]methyl}acetamide

SMILES

Cc1noc(C)c1CC(NCC(CC1)CCN1c1cc(-c2ccccc2)n[nH]1)=O

InChI

InChI=1S/C22H27N5O2/c1-15-19(16(2)29-26-15)12-22(28)23-14-17-8-10-27(11-9-17)21-13-20(24-25-21)18-6-4-3-5-7-18/h3-7,13,17H,8-12,14H2,1-2H3,(H,23,28)(H,24,25)

InChI Key

ZECYCTIABCNWHA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29012671

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.134

Distribution Coefficient, logD

3.134

Water Solubility, LogSw

-3.44

Polar Surface Area

71.882

Acid Dissociation Constant (pKa)

13.96

Base Dissociation Constant (pKb)

2.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

P807-0393 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P807-0393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P807-0393?
Check Price and Availability of P807-0393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P807-0393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P807-0393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P807-0393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P807-0393 available by request